The Japan Times - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.26336
AFN 72.539743
ALL 95.969597
AMD 436.761633
ANG 2.078085
AOA 1064.533294
ARS 1622.239954
AUD 1.665755
AWG 2.092209
AZN 1.969529
BAM 1.955155
BBD 2.333461
BDT 142.163126
BGN 1.984315
BHD 0.438291
BIF 3440.935805
BMD 1.160887
BND 1.482398
BOB 8.023389
BRL 6.057509
BSD 1.158533
BTN 108.556609
BWP 15.874697
BYN 3.429869
BYR 22753.389691
BZD 2.330162
CAD 1.601177
CDF 2643.919879
CHF 0.915354
CLF 0.026906
CLP 1062.339221
CNY 8.001646
CNH 8.006409
COP 4301.342579
CRC 539.805739
CUC 1.160887
CUP 30.763512
CVE 110.230079
CZK 24.422339
DJF 206.314639
DKK 7.471476
DOP 69.405023
DZD 153.81363
EGP 61.066959
ERN 17.413308
ETB 179.100647
FJD 2.600677
FKP 0.867445
GBP 0.864925
GEL 3.140219
GGP 0.867445
GHS 12.657881
GIP 0.867445
GMD 85.321598
GNF 10154.564337
GTQ 8.872189
GYD 242.46692
HKD 9.074133
HNL 30.67796
HRK 7.537175
HTG 151.908604
HUF 389.104442
IDR 19589.971991
ILS 3.616338
IMP 0.867445
INR 109.019845
IQD 1517.69958
IRR 1524273.954377
ISK 143.799761
JEP 0.867445
JMD 182.824207
JOD 0.823051
JPY 184.365141
KES 150.462767
KGS 101.518661
KHR 4649.426928
KMF 494.537784
KPW 1044.815161
KRW 1737.721097
KWD 0.355777
KYD 0.965482
KZT 559.295588
LAK 24943.775471
LBP 103754.689722
LKR 364.169925
LRD 212.602647
LSL 19.751088
LTL 3.427798
LVL 0.702209
LYD 7.38666
MAD 10.800599
MDL 20.263319
MGA 4837.30086
MKD 61.648395
MMK 2438.057732
MNT 4143.749921
MOP 9.336622
MRU 46.206372
MUR 53.934929
MVR 17.946995
MWK 2008.89436
MXN 20.584621
MYR 4.602915
MZN 74.19248
NAD 19.751088
NGN 1599.354434
NIO 42.635575
NOK 11.294841
NPR 173.683496
NZD 1.992756
OMR 0.446361
PAB 1.158523
PEN 4.007379
PGK 5.003307
PHP 69.633526
PKR 323.679158
PLN 4.267218
PYG 7559.605105
QAR 4.224862
RON 5.094906
RSD 117.448079
RUB 93.885915
RWF 1694.890056
SAR 4.354847
SBD 9.335826
SCR 15.98465
SDG 697.693459
SEK 10.763046
SGD 1.483788
SHP 0.870966
SLE 28.553338
SLL 24343.237318
SOS 662.061742
SRD 43.347429
STD 24028.021821
STN 24.491714
SVC 10.137657
SYP 128.798415
SZL 19.749403
THB 37.717178
TJS 11.116578
TMT 4.074714
TND 3.398223
TOP 2.795137
TRY 51.494061
TTD 7.871405
TWD 37.026486
TZS 2983.548704
UAH 50.880828
UGX 4338.513435
USD 1.160887
UYU 47.215042
UZS 14134.339587
VES 532.705795
VND 30589.378487
VUV 138.735394
WST 3.178743
XAF 655.726671
XAG 0.015845
XAU 0.000253
XCD 3.137356
XCG 2.088012
XDR 0.815514
XOF 655.749258
XPF 119.331742
YER 276.985155
ZAR 19.558738
ZMK 10449.374887
ZMW 21.926054
ZWL 373.805214
  • RBGPF

    -13.5000

    69

    -19.57%

  • RYCEF

    -0.2800

    15.69

    -1.78%

  • CMSC

    -0.0100

    22.87

    -0.04%

  • NGG

    0.2700

    82.33

    +0.33%

  • RELX

    -1.3500

    32.46

    -4.16%

  • BCC

    1.6900

    73.57

    +2.3%

  • GSK

    0.9600

    52.95

    +1.81%

  • BCE

    0.0700

    25.83

    +0.27%

  • RIO

    0.9300

    86.77

    +1.07%

  • BTI

    -0.1600

    57.76

    -0.28%

  • VOD

    0.1800

    14.66

    +1.23%

  • BP

    1.2200

    44.79

    +2.72%

  • CMSD

    -0.1100

    22.63

    -0.49%

  • JRI

    0.1800

    11.86

    +1.52%

  • AZN

    1.7100

    185.78

    +0.92%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

K.Okada--JT